$AMPH
Amphastar Pharmaceuticals, Inc.

2024 Q4 Form 10-Q Financial Statement

#000129718424000058 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $191.2M
YoY Change 5.9%
Cost Of Revenue $89.27M
YoY Change 23.73%
Gross Profit $101.9M
YoY Change -5.96%
Gross Profit Margin 53.31%
Selling, General & Admin $23.82M
YoY Change 24.95%
% of Gross Profit 23.36%
Research & Development $21.08M
YoY Change 26.48%
% of Gross Profit 20.68%
Depreciation & Amortization $9.793M
YoY Change 1.81%
% of Gross Profit 9.61%
Operating Expenses $44.89M
YoY Change 25.66%
Operating Profit $57.05M
YoY Change -21.51%
Interest Expense -$4.271M
YoY Change -131.17%
% of Operating Profit -7.49%
Other Income/Expense, Net -$9.365M
YoY Change 3.58%
Pretax Income $47.68M
YoY Change -25.07%
Income Tax $7.254M
% Of Pretax Income 15.21%
Net Earnings $40.43M
YoY Change -17.86%
Net Earnings / Revenue 21.14%
Basic Earnings Per Share $0.83
Diluted Earnings Per Share $0.78
COMMON SHARES
Basic Shares Outstanding 48.08M 48.68M
Diluted Shares Outstanding 51.86M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.5M
YoY Change -16.48%
Cash & Equivalents $192.1M
Short-Term Investments $58.38M
Other Short-Term Assets $20.16M
YoY Change 58.72%
Inventory $130.3M
Prepaid Expenses
Receivables $139.6M
Other Receivables $5.349M
Total Short-Term Assets $545.9M
YoY Change 0.54%
LONG-TERM ASSETS
Property, Plant & Equipment $295.4M
YoY Change 5.18%
Goodwill $3.256M
YoY Change 5.3%
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $23.66M
YoY Change -6.47%
Total Long-Term Assets $999.2M
YoY Change -0.24%
TOTAL ASSETS
Total Short-Term Assets $545.9M
Total Long-Term Assets $999.2M
Total Assets $1.545B
YoY Change 0.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.09M
YoY Change 6.62%
Accrued Expenses $119.2M
YoY Change -37.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $252.0K
YoY Change -37.0%
Total Short-Term Liabilities $159.0M
YoY Change -38.36%
LONG-TERM LIABILITIES
Long-Term Debt $596.4M
YoY Change -8.7%
Other Long-Term Liabilities $27.04M
YoY Change 72.22%
Total Long-Term Liabilities $27.04M
YoY Change -95.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $159.0M
Total Long-Term Liabilities $27.04M
Total Liabilities $817.5M
YoY Change -13.9%
SHAREHOLDERS EQUITY
Retained Earnings $530.8M
YoY Change 42.27%
Common Stock $6.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $290.8M
YoY Change 17.51%
Treasury Stock Shares
Shareholders Equity $727.7M
YoY Change
Total Liabilities & Shareholders Equity $1.545B
YoY Change 0.04%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $40.43M
YoY Change -17.86%
Depreciation, Depletion And Amortization $9.793M
YoY Change 1.81%
Cash From Operating Activities $59.96M
YoY Change -6.75%
INVESTING ACTIVITIES
Capital Expenditures $13.79M
YoY Change 35.23%
Acquisitions
YoY Change
Other Investing Activities -$20.79M
YoY Change -0.51%
Cash From Investing Activities -$34.59M
YoY Change 10.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -22.82M
YoY Change -126.35%
NET CHANGE
Cash From Operating Activities 59.96M
Cash From Investing Activities -34.59M
Cash From Financing Activities -22.82M
Net Change In Cash 2.560M
YoY Change -97.86%
FREE CASH FLOW
Cash From Operating Activities $59.96M
Capital Expenditures $13.79M
Free Cash Flow $46.17M
YoY Change -14.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Pension Expense
PensionExpense
0
CY2023Q3 us-gaap Pension Expense
PensionExpense
0
us-gaap Pension Expense
PensionExpense
0
CY2024Q3 us-gaap Pension Expense
PensionExpense
0
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Registrant Name
EntityRegistrantName
Amphastar Pharmaceuticals, Inc.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001297184
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity File Number
EntityFileNumber
001-36509
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0702205
dei Entity Address Address Line1
EntityAddressAddressLine1
11570 6th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Cucamonga
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91730
dei City Area Code
CityAreaCode
909
dei Local Phone Number
LocalPhoneNumber
980-9484
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AMPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48081433
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192116000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144296000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
58375000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
112510000
CY2024Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2023Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139635000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
114943000
CY2024Q3 us-gaap Inventory Net
InventoryNet
130316000
CY2023Q4 us-gaap Inventory Net
InventoryNet
105833000
CY2024Q3 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
5349000
CY2023Q4 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
526000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17723000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9057000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
545949000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
489600000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
295384000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282746000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
426000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
564000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31708000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32333000
CY2023Q4 amph Investment In Unconsolidated Affiliate
InvestmentInUnconsolidatedAffiliate
527000
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
594796000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
613295000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
14685000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23663000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25910000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53252000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53252000
CY2024Q3 us-gaap Assets
Assets
1545178000
CY2023Q4 us-gaap Assets
Assets
1512912000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153268000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
93366000
CY2023Q4 amph Accrued Payments For Asset Acquisitions
AccruedPaymentsForAssetAcquisitions
126090000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1281000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1609000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
252000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
436000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4209000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3906000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
159010000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
225407000
CY2024Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6066000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6066000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
596446000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589579000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28941000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29721000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27037000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22718000
CY2024Q3 us-gaap Liabilities
Liabilities
817500000
CY2023Q4 us-gaap Liabilities
Liabilities
873491000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60690076
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48372997
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59390194
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48068881
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
496427000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
486056000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
530823000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
409268000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8821000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8478000
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
290757000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
247431000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
727678000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
639421000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1545178000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1512912000
CY2024Q3 us-gaap Revenues
Revenues
191214000
CY2023Q3 us-gaap Revenues
Revenues
180556000
us-gaap Revenues
Revenues
545444000
us-gaap Revenues
Revenues
466290000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
89273000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
72153000
us-gaap Cost Of Revenue
CostOfRevenue
258237000
us-gaap Cost Of Revenue
CostOfRevenue
211309000
CY2024Q3 us-gaap Gross Profit
GrossProfit
101941000
CY2023Q3 us-gaap Gross Profit
GrossProfit
108403000
us-gaap Gross Profit
GrossProfit
287207000
us-gaap Gross Profit
GrossProfit
254981000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8995000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6407000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27378000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20234000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14821000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12654000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43782000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38418000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21077000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16664000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55772000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53322000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
44893000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35725000
us-gaap Operating Expenses
OperatingExpenses
126932000
us-gaap Operating Expenses
OperatingExpenses
111974000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
57048000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
72678000
us-gaap Operating Income Loss
OperatingIncomeLoss
160275000
us-gaap Operating Income Loss
OperatingIncomeLoss
143007000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2427000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1202000
us-gaap Investment Income Interest
InvestmentIncomeInterest
8320000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3156000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6698000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
13702000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
23918000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17702000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5094000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3459000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1125000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1553000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9365000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9041000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14473000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12993000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47683000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145802000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7254000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14025000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23674000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27160000
CY2024Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
40429000
CY2023Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
49612000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
122128000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
102854000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-390000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-573000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1476000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
40429000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
us-gaap Net Income Loss
NetIncomeLoss
121555000
us-gaap Net Income Loss
NetIncomeLoss
101378000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48621000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48701000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48580000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48368000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51862000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53921000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52307000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52997000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
40429000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
us-gaap Net Income Loss
NetIncomeLoss
121555000
us-gaap Net Income Loss
NetIncomeLoss
101378000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-87000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-343000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
213000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-87000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-343000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
213000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40434000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49135000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
121212000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
101591000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
639421000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43177000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-291000
CY2024Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-17311000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7360000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
672356000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
37949000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-57000
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8498000
CY2024Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
5816000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5780000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
713346000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
40429000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
34958000
CY2024Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
3260000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5596000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
727678000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
356000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8015000
CY2023Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-4565000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6111000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
548577000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56000
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
129000
CY2023Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
9853000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4865000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589235000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-87000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000
CY2023Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
2126000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4644000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
595140000
us-gaap Profit Loss
ProfitLoss
121555000
us-gaap Profit Loss
ProfitLoss
101378000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-110000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-474000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2700000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
-1496000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
1019000
us-gaap Depreciation
Depreciation
20992000
us-gaap Depreciation
Depreciation
18559000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18539000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6651000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3010000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2778000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5308000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8486000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-573000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1476000
us-gaap Share Based Compensation
ShareBasedCompensation
18736000
us-gaap Share Based Compensation
ShareBasedCompensation
15620000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24577000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30175000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24329000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6537000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10489000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-105000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
5147000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-25185000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2866000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2667000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
61451000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16625000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
184362000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
159639000
amph Payments Acquisitions Of Assets
PaymentsAcquisitionsOfAssets
129000000
amph Payments Acquisitions Of Assets
PaymentsAcquisitionsOfAssets
506406000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28630000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28724000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
47507000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
52802000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
118538000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38801000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
2653000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
-3064000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89252000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-546067000
amph Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsNetOfWithholdingTaxPayments
8234000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7414000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
43456000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
58144000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
838000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24589000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13565000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
845000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8148000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
268506000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47111000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
501176000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-179000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-44000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47820000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
114704000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144531000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156333000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
192351000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271037000
amph Deferred Payment For Acquisition
DeferredPaymentForAcquisition
121699000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5120000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4496000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
2386000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
9890000
us-gaap Interest Paid Net
InterestPaidNet
22389000
us-gaap Interest Paid Net
InterestPaidNet
12098000
us-gaap Income Taxes Paid
IncomeTaxesPaid
29000000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2136000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:14pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The principal accounting estimates include: fair value of acquired assets, fair value of financial instruments, allowance for discounts, provision for chargebacks and rebates, provision for product returns, adjustment of inventory to its net realizable value, impairment of investments, long-lived and intangible assets and goodwill, litigation reserves, stock price volatility for share-based compensation expense, valuation allowances for deferred tax assets, and liabilities for uncertain income tax positions.</p>
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1400000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
400000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-900000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-400000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2024Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2023Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
27920000
CY2022Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
26606000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
218312000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
200317000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
181216000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
201650000
CY2024Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
65016000
CY2023Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
25273000
CY2024Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
65016000
CY2023Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
27920000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
40429000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
us-gaap Net Income Loss
NetIncomeLoss
121555000
us-gaap Net Income Loss
NetIncomeLoss
101378000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48621000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48701000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48580000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48368000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3241000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
5220000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3727000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4629000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51862000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53921000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52307000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52997000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q3 us-gaap Revenues
Revenues
191214000
CY2023Q3 us-gaap Revenues
Revenues
180556000
us-gaap Revenues
Revenues
545444000
us-gaap Revenues
Revenues
466290000
CY2024Q3 us-gaap Gross Profit
GrossProfit
101941000
CY2023Q3 us-gaap Gross Profit
GrossProfit
108403000
us-gaap Gross Profit
GrossProfit
287207000
us-gaap Gross Profit
GrossProfit
254981000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
44893000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35725000
us-gaap Operating Expenses
OperatingExpenses
126932000
us-gaap Operating Expenses
OperatingExpenses
111974000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
57048000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
72678000
us-gaap Operating Income Loss
OperatingIncomeLoss
160275000
us-gaap Operating Income Loss
OperatingIncomeLoss
143007000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9365000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9041000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14473000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12993000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47683000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145802000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9793000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9619000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29131000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16081000
CY2024Q3 us-gaap Revenues
Revenues
191214000
CY2023Q3 us-gaap Revenues
Revenues
180556000
us-gaap Revenues
Revenues
545444000
us-gaap Revenues
Revenues
466290000
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
327518000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
315643000
CY2024Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
31903000
CY2024Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
67000
CY2024Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2000
CY2024Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
31968000
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
89517000
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
64000
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
22000
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
89559000
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P24Y
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
594071000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31756000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
562315000
CY2024Q3 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32481000
CY2024Q3 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32481000
CY2024Q3 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
626552000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31756000
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
594796000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P24Y
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
594364000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13510000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
580854000
CY2023Q4 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32441000
CY2023Q4 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32441000
CY2023Q4 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
626805000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13510000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
613295000
CY2023Q4 us-gaap Goodwill
Goodwill
3216000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
40000
CY2023 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
90000
CY2024Q3 us-gaap Goodwill
Goodwill
3256000
CY2023Q4 us-gaap Goodwill
Goodwill
3216000
CY2024Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
60536000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
50082000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
36016000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30822000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
33764000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
24929000
CY2024Q3 us-gaap Inventory Net
InventoryNet
130316000
CY2023Q4 us-gaap Inventory Net
InventoryNet
105833000
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
900000
us-gaap Inventory Write Down
InventoryWriteDown
10100000
us-gaap Inventory Write Down
InventoryWriteDown
9600000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
561573000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
528044000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
266189000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
245298000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
295384000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282746000
CY2024Q3 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
59949000
CY2023Q4 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
16702000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29207000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25203000
CY2024Q3 amph Product Return Accrual Current
ProductReturnAccrualCurrent
13480000
CY2023Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
12263000
CY2024Q3 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
812000
CY2023Q4 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
918000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15732000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12842000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119180000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
67928000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
34088000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25438000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153268000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
93366000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
485000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
616000
CY2024Q3 us-gaap Contractual Obligation
ContractualObligation
609218000
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
603790000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
252000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
436000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12520000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
13775000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
596446000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589579000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47683000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145802000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7254000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14025000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23674000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27160000
CY2024Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
40429000
CY2023Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
49612000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
122128000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
102854000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.152
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.162
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.402
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.413
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.414
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.044
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7762298
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
642985
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
46.27
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1611117
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
21138
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.10
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6773028
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M13D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
168760000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4968365
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y11M19D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
146600000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6617113
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
23.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y14D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
167346000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.76
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6218000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5628000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
48381000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
24544000
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3332000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2277000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9154000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12015000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
111000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
167000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9815000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8887000
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2076355
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
642985
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
893539
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
10.98
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
21138
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
16.19
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1804663
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.76
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5596000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4644000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18736000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15620000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2024Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2000000.0
CY2023Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2024Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0325
CY2023Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0325
CY2024Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2800000
CY2023Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2600000
CY2024Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
9400000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
6800000
CY2024Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
9800000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
7100000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001297184-24-000058-index-headers.html Edgar Link pending
0001297184-24-000058-index.html Edgar Link pending
0001297184-24-000058.txt Edgar Link pending
0001297184-24-000058-xbrl.zip Edgar Link pending
amph-20240930.xsd Edgar Link pending
amph-20240930x10q.htm Edgar Link pending
amph-20240930xex10d1.htm Edgar Link pending
amph-20240930xex31d1.htm Edgar Link pending
amph-20240930xex31d2.htm Edgar Link pending
amph-20240930xex32d1.htm Edgar Link pending
amph-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
amph-20240930_def.xml Edgar Link unprocessable
amph-20240930_lab.xml Edgar Link unprocessable
amph-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
amph-20240930_cal.xml Edgar Link unprocessable
amph-20240930x10q_htm.xml Edgar Link completed